Suppr超能文献

急性呼吸窘迫综合征患者肺部的细胞因子平衡

Cytokine balance in the lungs of patients with acute respiratory distress syndrome.

作者信息

Park W Y, Goodman R B, Steinberg K P, Ruzinski J T, Radella F, Park D R, Pugin J, Skerrett S J, Hudson L D, Martin T R

机构信息

Section of Pulmonary/Critical Care Medicine, Harborview Medical Center, Medical Research Service of the VA Puget Sound Health Care System, Seattle, Washington, USA.

出版信息

Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1896-903. doi: 10.1164/ajrccm.164.10.2104013.

Abstract

Acute respiratory distress syndrome (ARDS) involves an intense inflammatory response in the lungs, with accumulation of both pro- and antiinflammatory cytokines in bronchoalveolar lavage fluid (BALF). Our goal was to determine how the balance between pro- and antiinflammatory mediators in the lungs changes before and after the onset of ARDS. We identified 23 patients at risk for ARDS and 46 with established ARDS and performed serial bronchoalveolar lavage (BAL). We used immunoassays to measure tumor necrosis factor alpha (TNF-alpha) and soluble TNF-alpha receptors I and II; interleukin 1 beta (IL-1 beta), IL-1 beta receptor antagonist, and soluble IL-1 receptor II; IL-6 and soluble IL-6 receptor; and IL-10. We used sensitive bioassays to measure net TNF-alpha, IL-1 beta, and IL-6 activity. Although individual cytokines increased before and after onset of ARDS, greater increases occurred in cognate receptors and/or antagonists, so that molar ratios of agonists/antagonists declined dramatically at the onset of ARDS. The molar ratios remained low for 7 d or longer, limiting the activity of soluble IL-1 beta and TNF-alpha in the lungs at the onset of ARDS. This significant antiinflammatory response early in ARDS may provide a key mechanism for limiting the net inflammatory response in the lungs.

摘要

急性呼吸窘迫综合征(ARDS)涉及肺部强烈的炎症反应,支气管肺泡灌洗液(BALF)中促炎细胞因子和抗炎细胞因子均有蓄积。我们的目标是确定ARDS发病前后肺部促炎和抗炎介质之间的平衡如何变化。我们确定了23例有ARDS风险的患者和46例确诊ARDS的患者,并进行了系列支气管肺泡灌洗(BAL)。我们使用免疫测定法测量肿瘤坏死因子α(TNF-α)、可溶性TNF-α受体I和II;白细胞介素1β(IL-1β)、IL-1β受体拮抗剂和可溶性IL-1受体II;IL-6和可溶性IL-6受体;以及IL-10。我们使用灵敏的生物测定法测量TNF-α、IL-1β和IL-6的净活性。尽管在ARDS发病前后单个细胞因子均升高,但同源受体和/或拮抗剂升高幅度更大,因此在ARDS发病时激动剂/拮抗剂的摩尔比急剧下降。该摩尔比在7天或更长时间内保持较低水平,限制了ARDS发病时肺部可溶性IL-1β和TNF-α的活性。ARDS早期这种显著的抗炎反应可能是限制肺部净炎症反应的关键机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验